Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intra-articular Injection of Botulinum Toxin Type A in Hemiplegic Shoulder Pain: a Multicentric, Double Blind Randomised, Versus Steroid Study

NCT01473277 is registered in ClinicalTrials.gov with The Foundation Institute San Raffaele G. Giglio of Cefalù as lead sponsor.

NCT NCT01473277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01473277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intra-articular Injection of Botulinum Toxin Type A in Hemiplegic Shoulder Pain: a Multicentric, Double Blind Randomised, Versus Steroid Study
Lead sponsor
The Foundation Institute San Raffaele G. Giglio of Cefalù
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2012
Completion date
January 31, 2013
Enrollment
52 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemiparesis, shoulder pain, stroke